MiR-153 can inhibit migration and invasion of human NSCLC by targeting ADAM19; it also can act in this disease as tumor suppressor by inhibiting AKT expression and, consequently, inducing apoptosis of lung cancer cells [19, 20]. The gene discussed is ADAM19; the disease is non-small cell lung carcinoma.